These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases]. Giulini SM; Agus GB; De Cristoforo A Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376 [No Abstract] [Full Text] [Related]
5. [Treatment of some vascular diseases with the use of oxyphenyl-oxybutylamino-ethanol]. Berezovsky M; Berstein S Prensa Med Argent; 1966 Sep; 53(36):1964-71. PubMed ID: 4384691 [No Abstract] [Full Text] [Related]
6. [Treatment of arterial insufficiency in the lower extremities by intra-arterial injection]. van der Molen HR Phlebologie; 1987; 40(1):157-69. PubMed ID: 3575431 [No Abstract] [Full Text] [Related]
7. [Effect of Inderal on intermittent claudication in patients with obliterative arterial disease]. Skawiński S; Wójcikiewicz O; Peiker W Pol Tyg Lek; 1971 Dec; 26(52):2019-21. PubMed ID: 5139589 [No Abstract] [Full Text] [Related]
9. [Experiences with the new vasotherapeutic drug Trental in dermatology]. Herger R Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351 [No Abstract] [Full Text] [Related]
10. Local application of thymoxamine in peripheral vascular disease. Turner P; Harrison J; Schoenfeldt R Lancet; 1969 Jun; 1(7608):1238-9. PubMed ID: 4182414 [No Abstract] [Full Text] [Related]
11. [On drug therapy of phlebopathies of the lower extremities with trihydroxyethylrutoside and trihydroxyethylrutoside associated with adrenochromomonosemicarbazone]. Bagliani A; Taborelli R; Parravicini R Minerva Cardioangiol; 1973 Dec; 21(12):775-88. PubMed ID: 4780269 [No Abstract] [Full Text] [Related]
12. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication]. Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105 [No Abstract] [Full Text] [Related]
13. [An accessory factor in the therapy of leg ulcers and gangrene]. Bugár-Mészáros K; Kusztos D; Bereczky M; Galambos J Orv Hetil; 1968 Oct; 109(43):2377-9. PubMed ID: 5720081 [No Abstract] [Full Text] [Related]
14. [An organic nitrate preparation for the treatment of chronic arterial circulation disorders of the extremities]. Speckert H; Klepzig H; Strasburger KH Med Welt; 1966 Nov; 46():2511-3. PubMed ID: 5979456 [No Abstract] [Full Text] [Related]
15. [Conservative treatment of arterial insufficiency in the legs (1)]. Lund F Lakartidningen; 1968 Apr; 65(14):1435-48. PubMed ID: 4913094 [No Abstract] [Full Text] [Related]
17. [Clinical observation on the analgesic effect of the acetaminophen-phenylbutazone combination in angiology]. Guerra JC; Chaddad F; Goes S; Simi JC Hospital (Rio J); 1968 Jun; 73(6):1879-90. PubMed ID: 4890406 [No Abstract] [Full Text] [Related]
18. [Results of experimentation with pyridoxylate in angor and intermittent claudication]. Ganelina IE; Deryagina GP; Krivoruchenko IV Therapeutique; 1969 Jan; 45(1):74-6. PubMed ID: 5792158 [No Abstract] [Full Text] [Related]
19. [Insulin in the treatment of trophic disorders caused by chronic obliterating arteriopathies]. Cascone A; Ferrari F G Gerontol; 1968 Dec; 16(12):1385-94. PubMed ID: 5732590 [No Abstract] [Full Text] [Related]
20. [Streptokinase-streptodornase association, a powerful therapeutic agent affecting the venous factor in obliterating arteritis of the lower limbs]. Fux J; Cotin M Phlebologie; 1970; 23(3):303-5. PubMed ID: 5475594 [No Abstract] [Full Text] [Related] [Next] [New Search]